Search Results

2013 ; 8 : 1558 – 1562 . 9. Taketa T Sudo K Correa AM . Post chemoradiation surgical pathology stage can customize the surveillance strategy in patients with esophageal adenocarcinoma . J Natl Compr Canc Netw , in press . 10

, we performed a Web-based survey among pathologists at the Institute of Pathology of the Charité Medical University Berlin. In the survey, we presented the clinical information of a 54-year-old female patient with abdominal pain and the cytological

(45 U/L). Fiberoptic bronchoscopy was performed with fine-needle aspiration (FNA) of a station 7 lymph node, and the pathology was read as poorly differentiated squamous cell carcinoma (SCC) ( Figure 2 ). Immunostains were positive for p63 and negative

presence of bowel perforation or obstruction, specific systemic chemotherapy and targeted therapy agents, molecular pathology testing ( KRAS , BRAF , and microsatellite instability [MSI]), comorbidities, and hospital characteristics. Given the complex

are also adverse factors that may be considered. ” ASTR-2 No prior fractionated external-beam pathway: the term “progression” was removed. Anaplastic Gliomas/Glioblastoma GLIO-1 Under “Pathology,” “Anaplastic gliomas” was changed

chronic active HBV infection or exposure, monitor hepatitis viral load during and after therapy with an mTOR inhibitor Bank peripheral blood specimens and leftover archival pathology or cytology specimens for future research Characterize

hematologic malignancies is increasingly complex. Issues relating to pathology, transplantation, and various new therapies require oncologists and hematologists to stay abreast of breakthrough advances. In addition, targeted therapies and oral treatments bring

experience in evaluating pediatric melanocytic lesions. Relevant clinical information for the pathology requisition includes patient age; lesion location, color, and size; and whether the biopsy includes the entire lesion. A history of congenital nevus in the

Pathology The most recent WHO Classification of the Tumors of the Female Genital Tract provides comprehensive diagnostic criteria, pathologic features, and associated genetic alterations in an effort to increase consistency in pathologic diagnosis of these

pathology and federal regulations. Although obtaining tissue from patients may have associated risk and discomfort, individual patients and patient advocacy organizations are often eager to participate as true partners in the clinical research enterprise